Herceptin 440mg

Herceptin 440 is a prescription medication used to treat certain types of breast cancer and stomach cancer. It is a monoclonal antibody that targets the HER2 protein, which is found on the surface of some cancer cells.

Composition:

• Herceptin 440: Trastuzumab (440mg)

Mechanism of Action:

Herceptin 440 works by:

1. Binding to the HER2 protein on the surface of cancer cells, which can help to:
   • Prevent the growth and spread of cancer cells
   • Reduce the production of certain growth factors that can promote cancer growth
   • Enhance the effects of chemotherapy

Indications:

Herceptin 440 is approved for the treatment of:

• Metastatic breast cancer in women who have HER2-positive tumors
• Adjuvant breast cancer in women who have HER2-positive tumors and have undergone surgery
• Gastric cancer in patients with HER2-positive tumors

Dosage:

The recommended dosage of Herceptin 440 is:

• 440mg as an infusion over 90 minutes every 3 weeks
• The recommended duration of treatment is until disease progression or unacceptable toxicity occurs

Side Effects:

Common side effects of Herceptin 440 include:

1. Infusion reactions
2. Fatigue
3. Headache
4. Muscle pain
5. Nausea
6. Vomiting
7. Diarrhea
8. Abdominal pain
9. Fever
10. Chills

Recommendation:

Herceptin 440 is recommended for patients with HER2-positive breast cancer or gastric cancer who have not responded to other treatments.

Important Note:

• Patients taking Herceptin 440 should be closely monitored for signs of cardiac problems, such as heart failure or arrhythmias.
• Patients taking Herceptin 440 should avoid taking medications that may interact with it, such as anticoagulants or medications that can increase the risk of bleeding.
• Pregnant or breastfeeding women should not use Herceptin 440, as it may harm the fetus or infant.
• Regular follow-up appointments with your healthcare provider are necessary to monitor the effectiveness of Herceptin 440 and to detect any potential side effects or complications.

Special Precautions:

• Patients with a history of heart problems or liver disease should be closely monitored while taking Herceptin 440.
• Patients with a history of severe allergic reactions should be closely monitored while taking Herceptin 440.

Contraindications:

• Patients who are allergic to trastuzumab or any other component of Herceptin 440 should not use it.
• Patients who are pregnant or breastfeeding should not use Herceptin 440.
• Patients with severe liver disease or severe kidney disease should not use Herceptin 440.